Ranking the Diabetes-related Safety Profile of Different Statin Drugs
Different statins demonstrate varying associations with diabetes-related adverse events, with atorvastatin showing the strongest signal across age groups. These findings may inform clinical decisionmaking when prescribing statins, particularly for patients with pre-existing diabetes risk factors.
Authors
- Dongsheng Hong (ORCID: https://orcid.org/0000-0003-2695-6353)
- Duo Lv
- Jun Ren (ORCID: https://orcid.org/0000-0002-4613-2004)
- Dongsheng Zheng (ORCID: https://orcid.org/0000-0002-0862-6417)
- Qingwei Zhao (ORCID: https://orcid.org/0000-0002-7201-0588)
Institutions
- Zhejiang Chinese Medical University (CN)
- Zhejiang Provincial Hospital of TCM (CN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-09-22
- DOI
- https://doi.org/10.2174/0113816128430202250902074509
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.50